Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Antonelou, Roubina Ch; Emmanouilidou, Evangelia; Gasparinatos, Gerasimos; Velona, Theodora; Voumvourakis, Konstantinos I; Stefanis, Leonidas.
; 134(4): 748-55, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25962981
Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
That Wasn't a Complement-Too Much C3 in Demyelinating Disease.
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.
Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.